当前位置:

网站首页>文章详情

ST段抬高型心肌梗死合并心律失常治疗的历史变迁和现代进展

【PDF在线阅读】 【下载PDF】
  • Author:

  • Author Unit:

  • 关键词:

  • Keywords:

摘要:

Abstract:

基金项目:

北京市卫生系统高层次卫生技术人才培养项目资助(2009-3-68)

参考文献:

[1] Soar J,Donnino MW,Maconochie I,et al. 2018 International Consensus
on Cardiopulmonary Resuscitation and Emergency Cardiovascular
Care Science With Treatment Recommendations Summary[J].
Circulation,2018,138(23):e714-30.
[2] O'Gara PT,Kushner FG,Ascheim DD,et al. 2013 ACCF
/AHAguidelinefor the management of ST-elevation myocardial infarction: a report
of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines[J]. J Am Coll
Cardiol,2013,61(4):e78-e140.
[3] Ibanez B,James S,Agewall S,et al. 2017 ESC Guidelines for the
management of acute myocardial infarction in patients presenting
with ST-segment elevation: The Task Force for the management of
acute myocardial infarction in patients presenting with ST-segment
elevation of the European Society of Cardiology (ESC)[J]. Eur Heart
J,2018,39(2):119-77.
[4] Lüscher TF,Obeid S. From Eisenhower's heart attack to modern
management: a true success story[J]. Eur Heart J,2017,38(41):3066-9.
[5] Fye WB. The delayed diagnosis of myocardial infarction: it took half a
century![J]. Circulation,1985,72(2):262-71.
[6] Honey GE,Truelove SC. Prognostic factors in myocardial infarction[J].
Lancet,1957,272(6980):1155-61.
[7] Wahlberg F. A study of acute myocardial infarction at the Seraphimer
Hospital during 1950-1959[J]. Am Heart J,1963,65(6):749-957.
[8] Kouwenhoven WB,Jude JR,Knickerbocker GG. Closed-chest cardiac
massage[J]. JAMA,1960,173(10):1064-7.
[9] Zoll PM. Resuscitation of the heart in ventricular standstill by external
electric stimulation[J]. N Engl J Med,1952,247(20):768-71.
[10] Goble AJ,Sloman G,Robinson JS. Mortality reduction in a coronary care
unit[J]. Br Med J,1966,1(5494):1005-9.
[11] Julian DG,Valentine PA,Miller GG. Disturbances of rate,
rhythm and conduction in acute myocardial infarction[J]. Am J
Med,1964,37(6):915-27.
[12] Lown B,Fakhro AM,Hood WB,et al. The coronary care unit. New
perspectives and directions[J]. JAMA,1967,199(3):188-98.
[13] Noneman JW,Rogers JF. Lidocaine prophylaxis in acute myocardial
infarction[J].Medicine (Baltimore),1978,57(6):501-15.
[14] Breithardt G,Seipel L,Loogen F. Prognostic significance of arrhythmias
in acute myocardial infarction (author's transl)[J]. Z Kardiol,1977,66(6):
267-72.
[15] Mukharji J,Rude RE,Poole WK,et al. Risk factors for sudden death
after acute myocardial infarction:two-year follow-up[J]. Am J Cardiol,
1984,54(1):31-6.
[16] Furberg CD. Effect of antiarrhythmic drugs on mortality after
myocardial infarction[J]. Am J Cardiol,1983,52(6):32C-36C.
[17] Echt DS,Liebson PR,Mitchell LB,et al. Mortality and Morbidity in
Patients Receiving Encainide,Flecainide,or Placebo--The Cardiac
Arrhythmia Suppression Trial[J]. N Engl J Med,1991,324(12):781-8.
[18] Cardiac Arrhythmia Pilot Study (CAPS) Investigators. Effects of encai
nide,flecainide,imipramineand moricizine on ventricular arrhythmias
during the year after acute myocardial infarction: the CAPS[J]. Am J
Cardiol,1988,61(8):501-9.
[19] Cardiac Arrhythmia Suppression Trial (CAST) Investigators.
Preliminary report: effect of encainide and flecainide on mortality
in a randomized trial of arrhythmia suppression after myocardial
infarction[J]. N Engl J Med,1989,321(6):406-12.
[20] The Cardiac Arrhythmia Suppression Trial Ⅱ Investigators. Effect
of the Antiarrhythmic Agent Moricizine on Survival after Myocardial
Infarction[J]. N Engl J Med,1992,327(4):227-33.
[21] Connolly SJ. Meta-analysis of antiarrhythmic drug trials[J]. Am
JCardiol,1999,84(9A):90R-93R.
[22] Gunnar RM,Passamani ER,Bourdillon PD,et al. Guidelines for the
early management of patients with acute myocardial infarction.
A report of the American College of Cardiology/American Heart
Association Task Force on Assessment of Diagnostic and Therapeutic
Cardiovascular Procedures(Subcommittee to Develop Guidelines for
the Early Management of Patients with Acute Myocardial Infarction).
J Am CollCardiol,1990,16(2):249-92.
[23] Ryan TJ,Anderson JL,Antman EM,et al. ACC/AHA guidelines for the
management of patients with acute myocardial linfarction. A report of
the American College of Cardiology/American Heart Association Task
Forceon Practice Guidelines (Committeeon Management of Acute
Myocardial Infarction). J Am CollCardiol,1996,28(5):1328-428.
[24] Orejarena LA,Vidaillet H Jr,DeStefano F,et al. Paroxysmal
supraventricular tachycardia in the general population[J]. J Am CollC
ardiol,1998,31(1):150-7.
[25] Kathryn A,Wood, RN,et al. Frequency of Disabling Symptoms in
Supraventricular Tachycardia[J]. Am J Cardiol,1997,79(2):145-9.
[26] Katritsis DG,Boriani G,CosioFG,et al. European Heart Rhythm
Association (EHRA) consensus document on the management of
supraventricular arrhythmias,endorsed by Heart Rhythm Society
(HRS),Asia-Pacific Heart Rhythm Society(APHRS),and Sociedad
Latinoamericana de Estimulación Cardiaca y Electrofisiologia
(SOLAECE)[J]. Europace,2017,19(3):465-511.
[27] Wittwer MR,Rajendran S,Kealley J,et al. A South Australian registry of
biphasic cardioversions of atrial arrhythmias: efficacy and predictors of
success[J]. Heart Lung Circ,2015,24(4):342-7.
[28] Amsterdam EA,Kulcyski J,Ridgeway MG. Efficacy of cardioselective
beta-adrenergic blockade with intravenously administered metoprolol in
thetreatment of supraventricular tachyarrhythmias[J]. J Clin Pharmacol,
1991,31(8):714-8.
[29] Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the
diagnosis and treatment of acute and chronic heart failure: The Task
Force for the diagnosis and treatment of acute and chronic heart
failure of the European Society of Cardiology (ESC) Developed with
the special contribution of the Heart Failure Association (HFA) of the
ESC[J]. Eur Heart J,2016,37(27):2129-200.
[30] Delaney B,Loy J,Kelly AM. The relative efficacy of adenosine versus
verapamil for the treatment of stable paroxysmal supraventricular
t a c h y c a r d i a i n a d u l t s : a m e t a - a n a l y s i s [ J ] . E u r J E m e r g
Med,2011,18(3):148-52.
[31] Gupta A,Naik A,Vora A,et al. Comparison of efficacy of intravenous
diltiazem and esmolol in terminating supraventricular tachycardia[J].
J Assoc PhysiciansIndia,1999,47(10):969-72.
[32] Vietti-Ramus G,Veglio F,MarchisioU,et al. Efficacy and safety ofshort
intravenous amiodarone in supraventricular tachyarrhythmias[J]. Int J
Cardiol,1992,35(1):77-85.
[33] Priori SG,Blomstr?m-Lundqvist C,Mazzanti A,et al. 2015 ESC
Guidelines for the management of patients with ventricular
arrhythmias and the prevention of sudden cardiac death: The Task
Force for the Management of Patients with Ventricular Arrhythmias
and the Prevention of Sudden Cardiac Death of the European
Society of Cardiology (ESC). Endorsed by: Association for European
Paediatric and Congenital Cardiology (AEPC)[J]. Eur Heart J,2015,
36(41):2793-867.
[34] Swedberg K,Komajda M,Bo¨hm M,et al. Effects on outcomes of
heart rate reduction by ivabradine in patients with congestive heart
failure: is there an influence of beta-blocker dose? Findings from
the SHIFT(Systolic Heart failure treatment with the I(f) inhibitor
ivabradine Trial) study[J]. J AmCollCardiol,2012,59(22):1938-45.
[35] Arsura E,Lefkin AS,Scher DL,et al. A randomized, double-blind,
placebo-controlled study of verapamil and metoprololin treatment of
multifoc alatrial tachycardia[J]. Am J Med,1988,85(4):519-24.
[36] Brugada J,KatritsisDG,ArribasF,et al. 2019 ESC Guidelines for the
Management of Patients With Supraventricular tachycardia The
Task Force for the Management of Patients With Supraventricular
中国循证心血管医学杂志2019年12月第11卷第12期 Chin J Evid Based Cardiovasc Med,December,2019,Vol.11,No.12 ? 1417 ?
Tachycardia of the European Society of Cardiology (ESC)[J]. Eur
Heart J,2019,0(0):1-65.
[37] Gallagher MM,Guo XH,Poloniecki JD,et al. Initial energy setting,
outcome and efficiency in direct current cardioversion of atrial
fibrillation and flutter[J]. J Am CollCardiol,2001,38(5):1498-504.
[38] Brockmeier K,Ulmer HE,Hessling G. Termination of atrial reentrant
tachycardias by using transesophageal atrial pacing[J]. J Electrocardiol,
2002,35(Suppl):159-63.
[39] Da Costa A,Thevenin J,Roche F,et al. Results from the Loire-
Ardeche-Drome-Isere-Puy-de-Dome(LADIP) trialon atrial flutter,a
multicentric prospective randomized study comparing amiodarone
and radiofrequency ablation after the first episode of symptomatic
atrial flutter[J]. Circulation,2006,114(16):1676-81.
[40] Patel NJ,Deshmukh A,Pau D,et al. Contemporary utilization and safety
outcomes of catheter ablation of atrial flutter in the United States:
analysis of 89638 procedures[J]. Heart Rhythm,2016,13(6):1317-25.
[41] Bai R,Fahmy TS,Patel D,et al. Radiofrequency ablation of atypical
atrial flutter after cardiac surgery or atrial fibrillation ablation:
a randomized comparison of open-irrigation-tip and 8-mm-tip
catheters[J]. Heart Rhythm,2007,4(12):1489-96.
[42] Ho KM,Tan JA. Benefits and risks of corticosteroid prophylaxis in
adult cardiacsurgery:a dose-response meta-analysis[J]. Circulation,
2009,119(14):1853-66.
[43] Das G,Tschida V,Gray R,et al. Efficacy ofesmolol in the treatment and
transfer of patients with supraventricular tachyarrhythmias to alternate
oral antiarrhythmic agents. J Clin Pharmacol,1988,28(8):746-50.
[ 4 4 ] G a m b h i r D S , B h a r g a v a M , N a i r M , et al. C o m p a r i s o n o f
electrophysiologic effects and efficacy of single-dose intravenous
and long-term oral amiodarone therapy in patients with AV nodal
reentrant tachycardia[J]. Indian HeartJ,1996,48(2):133-7.
[45] Arkowski MM,Pytkowski M,Maciag A,et al. Gender-related differences in
outcomes and resource utilization in patients undergoing radiofrequency
ablation of supraventricular tachycardia: results from Patients’
Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT
Study[J]. Europace,2014,16(12):1821-7.
[46] Hamdan M,Van Hare GF,Fisher W,et al. Selective catheter ablation
of the tachycardia focus in patients with nonreentrant junctional
tachycardia[J]. Am J Cardiol,1996,78(11):1292-17.
[47] Arena G,Bongiorni MG,Soldati E,et al. Incessant nonreentrant
atrioventricular nodal tachycardia due to multiple nodal pathways
treated by radiofrequency ablation of the slow pathways[J]. J
Cardiovasc Electrophysiol,1999,10(12):1636-42.
[48] Roth A,Elkayam I,Shapira I,et al. Effectiveness of prehospital
synchronous direct-current cardioversion for supraventricular
tachyarrhythmias causing unstable hemodynamic states[J]. Am J
Cardiol,2003,91(4):489-91.
[49] Huycke EC,Sung RJ,Dias VC,et al. Intravenous diltiazem for
termination of reentrant supraventricular tachycardia: a placebo
controlled, randomized, double-blind, multicenter study[J]. J Am
CollCardiol,1989,13(3):538-44.
[50] Tijunelis MA,Herbert ME. Myth: Intravenous amiodarone is safe in
patients with atrial fibrillation and Wolff-Parkinson-White syndrome
in the emergency department[J]. CJEM,2005,7(4):262-5.
[51] Spector P,Reynolds MR,Calkins H,et al. Meta-analysis of ablation of
atrial flutter and supraventricular tachycardia[J]. Am J Cardiol,2009,
104(5):671-7.
[52] Pappone C,Vicedomini G,Manguso F,et al. Wolff-Parkinson-White
syndrome in the era of catheter ablation: insights from a registry study
of 2169 patients[J]. Circulation,2014,130(10):811-9.
[53] Ruiz-Nodar JM,Marin F,Hurtado JA,et al. Anticoagulant and
antiplatelet therapy use in 426 patients with atrial fibrillation
undergoing percutaneous coronary intervention and stent
implantation implications for bleeding risk and prognosis[J]. J Am
CollCardiol,2008,51(8):818-25.
[54] Lamberts M,Olesen JB,Ruwald MH,et al. Bleeding after initiation
of multiple antithrombotic drugs, including triple therapy, in atrial
fibrillation patients following myocardial infarction and coronary
intervention: a nationwide cohort study[J]. Circulation,2012,126(10):
1185-93.
[55] Kirchhof P,Benussi S,Kotecha D,et al. 2016 ESC Guidelines for the
management of atrial fibrillation developed in collaboration with
EACTS[J]. Eur Heart J,2016,37(38):2893-962.
[56] January CT,Wann LS,Calkins H,et al. 2019 AHA/ACC/HRS Focused
Update of the 2014 AHA/ACC/HRS Guideline for the Management of
Patients With Atrial Fibrillation: A Report of the American College
of Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines and the Heart Rhythm Society in Collaboration
With the Society of Thoracic Surgeons[J]. Circulation,2019,140(2):
e125-e151.
[57] Singh BN,Singh SN,Reda DJ,et al. Amiodarone versus sotalol for
atrial fibrillation[J]. N Engl J Med,2005,352(18):1861-72.
[58] Torp-Pedersen C,Camm AJ,Butterfield NN,et al. Vernakalant:
conversion of atrial fibrillation in patients with ischemic heart
disease[J]. Int JCardiol,2013,166(1):147-51.
[59] Klein AL,Grimm RA,Murray RD,et al. Use of transesophageal
echocardiography to guide cardioversion in patients with atrial
fibrillation[J]. N Engl J Med,2001,344(19):1411-20.
[60] Letelier LM,Udol K,Ena J,et al. Effectiveness of amiodarone for
conversion of atrial fibrillation to sinus rhythm: a meta-analysis[J].
Arch Intern Med,2003,163(7):777-85.
[ 6 1 ] M a r r o u c h e N F , B r a c h m a n n J , A n d r e s e n D , et al. C a t h e t e r
ablation for atrial fibrillation with heart failure[J]. N Engl J
Med,2018,378(5):417-27.
[62] Lip GYH,Banerjee A,Boriani G,et al. Antithrombotic Therapy for
Atrial Fibrillation: CHE ST Guideline and Expert Panel Report[J].
Chest,2018,154(5):1121-201.
[63] Lip GYH,Collet JP,Haude M,et al. Management of antithrombotic
therapy in AF patients presenting with ACS and/or undergoing
PCI:A Summary of the Joint Consensus Document of the European
Heart Rhythm Association (EHRA), European Society of Cardiology
Working Group on Thrombosis, European Association of Percutaneous
Cardiovascular Interventions (EAPCI) and European Association of
Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society
(HRS),Asia-Pacific Heart Rhythm Society (APHRS),Latin America
Heart Rhythm Society (LAHRS),and Cardiac Arrhythmia Society of
Southern Africa (CASSA)[J]. Eur Heart J,2018,39(31):2847-50.
[64] Gladstone DJ,Spring M,Dorian P,et al. EMBRACE Investigators and
Coordinators. Atria l fibrillation in patients with cryptogenic stroke[J].
N Engl J Med,2014,370(26):2467-77.
[65] Swedberg K,Zannad F,McMurray JJ,et al. Eplerenone and atrial
fibrillation in mild systolic heart failure: results from the EMPHASISHF
(Eplerenone in Mild Patients Hospitalization AndSurvivalStudy
in Heart Failure) study[J]. J Am CollCardiol,2012,59(18):1598-603.
[66] Al-Khatib SM,Stevenson WG,Ackerman MJ,et al. 2017AHA/ACC/HRS
Guideline for Management of Patients With Ventricular Arrhythmias and
the Prevention of Sudden Cardiac Death: Executive Summary: A Report
of the American College of Cardiology/American Heart Association Task
Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. J
Am CollCardiol,2018,72(14):1677-749.
[67] Jabbari R,Engstrom T,Glinge C,et al. Incidence and risk factors of
中国循证心血管医学杂志2019年12月第11卷第12期 Chin J Evid Based Cardiovasc Med,December,? 1418 ? 2019,Vol.11,No.12
ventricular fibrillation before primary angioplastyin patients with
first ST-elevation myocardial infarction: a nationwide study in
Denmark[J]. J Am Heart Assoc,2015,4(1):e001399.
[68] Mehta RH,Starr AZ,Lopes RD,et al. Incidence of and outcomes
associated with ventricular tachycardia or fibrillation in patients
undergoing primary percutaneous coronary intervention[J]. JAMA,
2009,301(17):1779-89.
[69] Demidova MM,Carlson J,Erlinge D,et al. Predictors of ventricular
fibrillation at reperfusion in patients with acute ST-elevation
myocardial infarction treated by primary percutaneous coronary
intervention[J]. Am J Cardiol,2015,115(4):417-22.
[70] Podolecki T,Lenarczyk R,Kowalczyk J,et al. Prognostic significance of
complex ventricular arrhythmias complicating ST-segment elevation
myocardial infarction[J]. Am J Cardiol,2018,121(7):805-9.
[71] Ottervanger JP,Ramdat Misier AR,Dambrink JH,et al. Mortality in
patients with left ventricular ejection fraction≤30% after primary
percutaneous coronary intervention for ST-elevation myocardial
infarction[J]. Am J Cardiol,2007,100(5):793-7.
[72] Volpi A,Cavalli A,Franzosi MG,et al. One-year prognosis of primary
ventricular fibrillation complicating acute myocardial infarction.
The GISSI (Gruppo Italiano per lo Studio dell a Streptochinasi
nell'Infarto miocardico) investigators[J]. Am J Cardiol,1989,63(17):11
74-8.
[73] Mozaffarian D,Benjamin EJ,Go AS,et al. Heart disease and stroke
statistics—2015 up date:a report from the American Heart
Association[J]. Circulation,2015,131(4):e29-e322.
[74] Dumas F,Cariou A,Manzo-Silberman S,et al. Immediate percutaneous
coronary intervention is associated with better survival after outof-
hospital cardiac arrest: insights from the PROCAT (Parisian
Region Out of hospital Cardiac Arrest) registry[J]. Circ Cardiovasc
Interv,2010,3(3):200-7.
[75] Terkelsen CJ,Sorensen JT,Kaltoft AK,et al. Prevalence and
significance of accelerated idioventricular rhythm inpatients with STelevation
myocardial infarction treated with primary percutaneous
coronary intervention[J]. AmJCardiol,2009,104(12):1641-6.
[76] Kalarus Z,Svendsen JH,Capodanno D,et al. Cardiac arrhythmias
in the emergency settings of acute coronary syndrome and
revascularization: an European Heart Rhythm Association (EHRA)
consensus document, endorsed by the European Association of
Percutaneous Cardiovascular Interventions (EAPCI), and European
Acute Cardiovascular Care Association (ACCA)[J]. Europace,2019,
21(10):1603-4.
[77] 黄德嘉,霍勇,张澍,等. 冠心病血运重建后心脏性猝死的预防[J].
中华心律失常学杂志,2017,21(1):9-21.
[78] Owens DK,Sanders GD,Heidenreich PA,et al. Effect of risk
stratification on cost-effectiveness of the implantable cardioverter
defibrillator[J]. Am Heart J,2002,144(3):440-8.
[79] Vaseghi M,Barwad P,Malavassi Corrales FJ,et al. Cardiac sympathetic
denervation for refractory ventricular arrhythmias[J]. J Am Coll Cardiol,
2017,69(25):3070-80.
[80] Kumar S,Sivagangabalan G,Thiagalingam A,et al. Effect of reperfusion
time on inducible ventricular tachycardia early and spontaneous
ventricular arrhythmias late after ST elevation myocardial infarction
treated with primary percutaneous coronary intervention[J]. Heart
Rhythm,2011,8(4):493-9.
[81] Jernberg T,Johanson P,Held C,et al. Association between adoption of
evidence-based treatment and survival for patients with ST-elevation
myocardial infarction[J]. JAMA,2011,305(16):1677-84.
[82] Yancy CW,Jessup M,Bozkurt B,et al. 2016 ACC/AHA/HFSA Focused
update on new pharmacological therapy for heart failure: an update of
the 2013 ACCF/AHA guideline for the management of heart failure:
a report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the Heart
Failure Society of America[J]. J Am CollCardiol,2016,68(13):1476-88.
[83] Olgin JE,Pletcher MJ,Vittinghoff E,et al. Wearable Cardioverter-
Defibrillator after Myocardial Infarction[J]. N Engl J Med,2018,379
(13):1205-15.
[84] Okamoto A,Inoue S,Tanaka Y,et al. Application of prophylactic
gel-pads for transcutaneous pacing in patients with complete right
bundle-branch block with axis deviation when surgical procedures
are performed:10-year experience from a single Japanese university
hospital[J]. J Anesth,2009,23(4):616-9.
[85] Brignole M,Auricchio A,Baron-Esquivias G,et al. 2013 ESC
guidelines on cardiac pacing and cardiac resynchronization therapy:
the Task Force on Cardiac Pacing and Resynchronization Therapy of
the European Society of Cardiology (ESC). Developed in collaboration
with the European Heart Rhythm Association (EHRA)[J]. Eur Heart
J,2013,34(29):2281-92.
[86] Kusumoto FM,Schoenfeld MH,Barrett C,et al. 2018 ACC/AHA/HRS
Guideline on the Evaluation and Management of Patients With
Bradycardia and Cardiac Conduction Delay: A Reportof the American
College of Cardiology/American Heart Association Task Force
on Clinical Practice Guidelines and the Heart Rhythm Society[J].
Circulation,2019,140(8):e382-e482.
[87] Brignole M,Moya A,de Lange FJ,et al. 2018 ESC Guidelines
for the diagnosis and management of syncope[J]. Eur Heart
J,2018,39(21):1883-948.
  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com